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Abstract  
Sensitivity to external demands is essential for adaptation to dynamic environments, but comes at 
the cost of increased risk of adverse outcomes when facing poor environmental conditions. Here, 
we apply a novel methodology to perform genome-wide association analysis of mean and 
variance in ten key brain features (accumbens, amygdala, caudate, hippocampus, pallidum, 
putamen, thalamus, intracranial volume, cortical surface area and cortical thickness), integrating 
genetic and neuroanatomical data from a large lifespan sample (n=25,575 individuals; 8 to 89 
years, mean age 51.9 years). We identify genetic loci associated with phenotypic variability in 
thalamus volume and cortical thickness. The variance-controlling loci involved genes with a 
documented role in brain and mental health and were not associated with the mean anatomical 
volumes. This proof-of-principle of the hypothesis of a genetic regulation of brain volume 
variability contributes to establishing the genetic basis of phenotypic variance (i.e., heritability), 
allows identifying different degrees of brain robustness across individuals, and opens new 
research avenues in the search for mechanisms controlling brain and mental health.  
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Introduction  
Phenotypic variability is key in evolution, and partly reflects inter-individual differences in 
sensitivity to the environment 1. Genetic studies of human neuroanatomy have identified shifts in 
mean phenotype distributions (e.g., mean brain volumes) between groups of individuals with 
different genotypes 2, and have documented genetic overlaps with common brain and mental 
disorders 3. Despite the evolutionary relevance of phenotypic dispersion evidenced in multiple 
species and traits 1, 4, the genetic architecture of variability in human brain morphology is 
elusive.  
 Phenotypic variance across genotypes can be interpreted in relation to robustness, i.e., the 
persistence of a system under perturbations 1, 4 and evolvability, the capacity for adaptive 
evolution 5. High phenotypic robustness is indicated by low variation in face of perturbations, i.e. 
phenotypes are strongly determined by a given genotype. In contrast, lack of robustness 
corresponds to high sensitivity, yielding phenotypes with overall larger deviations from the 
population mean in response to environmental, genetic or stochastic developmental factors. 
Neither increased or decreased robustness confers evolutionary advantages per se 1, and their 
consequences for adaptation need to be understood in view of the genotype-environment 
congruence. Reduced robustness (and thus increased variability of trait expression) can be a 
conducive to adaptive change 5, and increased variability of phenotypic expression can in itself 
also be favored by natural selection in fluctuating environments 6. Thus, recognizing genetic 
markers of sensitivity can aid in identifying individuals who are more susceptible to show 
negative outcomes when exposed to adverse factors –either genetic or environmental– and 
otherwise optimal outcomes in the presence of favorable factors. Such variance-controlling 
genotypes may be conceived as genomic hotspots for gene-environment and/or gene-gene 
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interactions, with high relevance for future genetic epidemiology studies 7. Data from this type of 
approaches may complement existing genetic association methods and contribute to establish the 
genetic basis of phenotypic variance (i.e., heritability), allow identifying different levels of brain 
robustness across subjects, and open new research avenues in the search for mechanisms 
controlling brain and mental health.  
 To provide a proof-of-principle of the hypothesis of a genetic regulation of brain volume 
variability, we conducted a genome-wide association study of intragenotypic variability in seven 
key subcortical regions and intracranial volume (ICV) using a harmonized genotype and imaging 
data analysis protocol in a lifespan sample (n=25,575 individuals; 8 to 89 years, mean age 51.9 
years; 48% male, Methods and Supplementary Table S1 and Supplementary Table S2). 
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Materials and Methods  
Participants  
Data from 25,575 unrelated European-ancestry individuals were included (mean age 51.9 years, 
ranging from 8 to 89 years old; 48% male), recruited through 16 independent cohorts with 
available genome-wide genotyping and T1-weighted structural MRI. Extended information on 
each cohort reported in Supplementary Methods and Supplementary Table 1 includes 
recruitment center, genotyping and brain imaging data collection, sample-specific demographics, 
distribution of brain volumes and, when relevant, diagnoses (795 individuals had a diagnosis). 
Written informed consent was provided by the participants at each recruitment center, and the 
protocols were approved by the corresponding Institutional Review Boards.  
 
Genotypes  
Only participants with European ancestry (as determined by multidimensional scaling) were 
included in the final set of analyses, in recognition that the inclusion of subjects from other 
ethnicities can potentially add genetic and phenotypic confounding. Except for the UK Biobank 
cohort, all directly genotyped data were imputed in-house using standard methods with the 1000 
Genomes European reference panel. After imputation, each genotyping batch underwent a 
quality control stage (MAF < 0.01; Hardy-Weinberg equilibrium p < 10-6; INFO score < 0.8). 
When all samples were combined, over 5 million distinct markers passed quality control 
genome-wide. Additional filters on genotyping frequencies were applied to the final merged 
dataset based on statistical considerations for genotype frequency in variance-controlling 
detection, as described below. Genetic data analysis was conducted using PLINK 8, with R 9 
plugin functions when appropriate (https://www.cog-genomics.org/plink/1.9/rserve).  
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Brain features  
Three-dimensional T1-weighted brain scans were processed using FreeSurfer 10 (v5.3.0; 
http://surfer.nmr.mgh.harvard.edu). Mean cortical thickness and eight well-studied volumetric 
features were selected for analysis moving forward, as literature findings on large datasets show 
that their mean population value is influenced by common genetic variation 2: accumbens, 
amygdala, caudate, hippocampus, pallidum, putamen, thalamus and ICV. Cohort-wise 
distribution of values is summarized in Supplementary Figure S1 and Supplementary Figure S2. 
Generalized additive models (GAM) were implemented in R (https://www.r-project.org) to 
regress out the effects of scanning site, sex, age, diagnosis and ICV (for subcortical volumes and 
cortical surface only), and outliers (±6 standard deviations from the mean) were removed. 
Hereafter, brain volumes correspond to residuals from those GAM fits unless otherwise 
specified. As noticed on violin plots of brain features stratified by sample (Supplementary Figure 
S1), some of the traits display a wider distribution in the UK Biobank than in the other cohorts, 
which may be related to a broader phenotypic repertoire captured by a much larger sample size; 
in addition, at each cohort, individuals on the very ends of the distributions might have been 
considered outliers/anomalous, and were probably removed at each imaging center during early 
quality control stages. 
 
Statistical analyses  
Genome-wide association statistics were computed for genetic effects on the mean and variance 
of the volumetric feature distributions in multiple stages. The data were analyzed and visualized 
in R with the aid of appropriate packages. Although the current dataset includes subjects across a 
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broad range of ages, the cross-sectional nature of the data (one image per individual) makes the 
main focus of the models below the analysis of gene-gene (epistasis) and gene-environment 
interactions. For each marker, an additive genetic model was computed with  = β + β sample + β + β + β + β + β SNP +  
where  is the normalized phenotype variable; SNP is the relevant marker coded additively and  
stands for regression residuals. Four genomic principal components ( - ) were included, to 
control for population stratification and cryptic relatedness, and to make the results 
consistent/comparable with a previous large-scale analysis of genetic variation and brain 
volumes 2. Then, the distribution of residuals ( ) was normalized via rank-based inverse normal 
transformation (INT) to prevent statistical artifacts. Scale transformations like INT have been 
shown to aid genetic discovery by constraining mean-effects and reducing the effect of 
phenotypic outliers, which reduces Type I error rates without sacrificing power 11, 12. 
Specifically, INT was applied to transform each subject’s residualized phenotype ( ) as  
INT = ϕ rank − 0.5  
where rank  is the rank within the distribution,  stands for sample size (without missing 
values) and ϕ  denotes the standard normal quantile function. Intuitively, all phenotype values 
are ranked and the ranks are mapped to percentiles of a normal distribution. Those INT-
transformed residuals were passed as input for the variance-model using Levene’s test centered 
at the median, implemented with R’s car package (https://cran.r-project.org/package=car). In 
short, = − ̃  is calculated from the transformed residuals, with ̃  as the median of 
group  (here, genotype) and these, in turn, to compute the  statistic:  
= ∑ ̅∙ ∙̅∙∑ ∑ ̅ ̅∙ , 
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where  is the number of observations in group ,  is the number of groups (2 or 3 different 
genotypes), and ∙̅  denotes the mean in group . For potentially significant associations, 
between-sample differences in minor allele frequencies were assessed, to avoid spurious results 
due to issues with genotype imputation. Also, to prevent increases in false positive rates arising 
from small groups 13, only markers with at minimum (non-zero) genotype count of at least 100 
were included. This value was chosen based on literature about power and statistical 
considerations of genome-wide association studies for phenotypic variability 13.  
 An additional validation stage was implemented in recognition that, despite the 
conservativeness of the previous approach, variables like sex and batch might still confound the 
variance test results 14, 15. Generalized additive models for location scale and shape (GAMLSS) 
were applied to the top significant results from Levene’s tests. Variants were selected for 
additional inspection based on their p-values in the variance analysis, using linkage 
disequilibrium-based clumping with default parameters on PLINK (Levene’s test p-values below 
1×10-4 over 250kb windows and an LD threshold of r2=0.5, http://www.cog-
genomics.org/plink/1.9/postproc#clump). As indicated next, this resulted in 1,799 genotype-
phenotype associations that were further examined via GAMLSS. For consistency with Levene’s 
test (which does not have a pre-specified inheritance model), GAMLSS tests were evaluated 
under 4 relevant paradigms: additive scale (A1 allele coded as continuous: 0, 1 or 2), dominant-
like (0 copies of A1 allele vs either 1 or 2 copies), recessive-like (2 copies of A1 allele vs either 
1 or 0 copies) and heterozygote (dis)advantage-like (1 copy of A1 vs either 0 or 2 copies). This 
resulted in 1,799 times 4 = 7,196 tests.  
Briefly, GAMLSS are semi-parametric regression type models that allow the parameters 
of the distribution of the response variable (mean, variance, skewness and kurtosis) to be 
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modelled as linear/non-linear or smooth functions of the explanatory variables 16. Here, mean 
and dispersion in the distribution of raw brain phenotypes (as extracted from FreeSurfer) were 
modeled as a function of genotype, sex, scanner, diagnose, ICV (when relevant) and an 
additional P-spline term for age as function of sex, through penalized varying coefficients with 
10 intervals 16, 17. GAMLSS were fitted through a normal distribution with the default identity 
link for location ( ) and log link for scale ( ). Unless otherwise specified, all other parameters 
were set to default from R’s GAMLSS implementation. It is worth noting that Levene’s test was 
here adopted as main discovery strategy as it provides some advantages over the GAMLSS’ R 
implementation, e.g.: GAMLSS are computationally more expensive (from seconds to minutes 
per marker-phenotype test), and do not allow different inheritance models to be directly tested in 




Genome-wide association statistics were computed for genetic effects on the variance and mean 
of the volumetric feature distributions. Consistent with previous large-scale analyses on genetics 
of neuroimaging volumetric measures 2, 18, features included bilateral (sum of left and right) 
amygdala, caudate nucleus, hippocampus, nucleus accumbens, pallidum, putamen and thalamus, 
as well as ICV and mean cortical thickness. 96.9% of the included participants were healthy 
controls (n=24,780); the remaining 3.1% were diagnosed with a brain disorder (n=795; including 
psychosis, depression, and attention deficit hyperactivity disorder, Supplementary Table S2). The 
analyses were conducted in a two-stage protocol. For each genotype, we conducted a standard 
association test for the GAM-transformed brain volumes 11, adjusting for scanning site, sex, age, 
diagnosis, and ICV (for the subcortical volumes only). Residuals from that model were then 
INT-transformed and submitted to genome-wide Levene’s tests to investigate if specific alleles 
associate with elevated or reduced levels of phenotypic variability. For relevant markers, 
variances explained by mean and variance models were estimated from the INT-transformed 
volumes before fitting regression models using a previously reported approach 7.  
A mega-analysis of 25,575 unrelated subjects of European ancestry identified candidate 
loci associated with differential levels of phenotypic variability overall on two out of the ten 
volumetric features (mean thickness and thalamus) (Figure 1). A loci displayed an association 
with Pallidum volume (Supplementary Figure S3) but was discarded as between-cohort allelic 
frequencies showed significant differences, indicating potential uncertainty in genotype 
imputation. Genomic inflation factors (lambda) ranged between 1.01 and 1.07 for the ten 
different variance-GWAS (Supplementary Figure S3). A conventional mean phenotype GWAS 
with additive model on the same set of variants, with INT-transformed phenotypes, showed 70 
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significant loci influencing four volumetric traits after adjustment for genomic inflation 
(accumbens [2], amygdala [5], caudate [10], hippocampus [12], pallidum [7], putamen [6], 
thalamus [4], ICV [9], cortical surface area [7] and mean cortical thickness [8]) (Supplementary 
Figure S3). Manhattan plots for both mean- and variance-GWAS are displayed as Supplementary 
Figure S3.  
 
[Insert Figure 1] 
 
In the variance analysis, the top association was a locus in chromosome 20 between 
SNAP25, PAK7 and ANKEF1, linked to mean cortical thickness variability (rs6039642; 
chr20:9940475:G:A; MAF=0.17; p=2.3×10-8; variance explained variance model: 0.129%; 
variance explained mean model: 0.003%). In addition, an intergenic locus near LINC00347 
showed a borderline significant association with variance in thalamus volumes (rs9543733; 
chr13:75211673:C:T; MAF=0.34; p=6.8×10-8; variance explained mean model: 0.002%; 
variance explained variance model: 0.054%) (Figure 1 and Supplementary Figure S4). Between 
cohorts, no clear differences in allelic frequencies were observed at these loci (MAF between 
0.15 and 0.199 at rs6039642, and MAF between 0.35 and 0.37 at rs9543733). Results were 
consistent when re-analyzing the data from healthy controls only (excluding participants with 
neuropsychiatric diagnoses), and when validating via GAMLSS: p=6.8×10-5 (rs6039642-cortical 
thickness), p=4.8×10-4 (rs9543733-thalamus). Males displayed higher variability than females in 
thalamus volumes according to those GAMLSS models (B=0.047, SE=0.011, p=1.9×10-5), and a 
trend-significant association for higher variability in cortical thickness (B=0.036, SE=0.021, 
p=0.082). Figure 2 shows the relevant phenotype distributions for the top hits for the two models 
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grouped by genotypes generated via the shift function 19. In short, the adopted shift function 
procedure was implemented in three stages: deciles of two phenotype distributions were 
calculated using the Harrell-Davis quantile estimator, followed by the computation of 95% 
confidence intervals of decile differences with bootstrap estimation of deciles’ standard error, 
and multiple comparison control so that the type I error rate remained close to 5% across the nine 
confidence intervals. Decile-by-decile shift function analysis confirmed increased thalamus 
variance among TC heterozygotes than rs9543733 homozygotes (TT, CC). Similarly, major 
allele homozygous subjects for rs6039642 (GG genotype) showed lower cortical thickness 
variance than carriers of the minor allele A.  
 
[Insert Figure 2] 
 
 As mentioned on Methods, associations from the variance models were further examined 
to discard potential artifacts, as variables like sex and batch might still confound the test results. 
Using standard clumping methods on the ten variance-GWAS, the top 1,799 genotype-phenotype 
associations were selected for additional analysis using GAMLSS. As observed above for the the 
pallidum variance-GWAS hit, some of the top markers obtained with Levene’s test can be 
susceptible to genotype imputation quality problems that influence variability in between-cohort 
genotype frequencies and might artificially introduce bias. Hence, markers that were both 
unavailable for one or more cohorts and had strong between-cohort differences in genotype 
frequencies (indexed by a chi-square test p<10-25) were excluded from the plots, giving a total of 
1,526 loci clumped from Levene’s test p-values. Results from Supplementary Figure S5 suggest 
that Levene’s test p-values are not particularly skewed towards false positives and, in some cases 
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(e.g., thalamus, Figure S5i), GAMLSS p-values might be smaller than the output from their 
Levene’s test-based counterpart. In view of those observations, we believe that a conservative 




To our knowledge, this is the first evidence of genetic loci influencing variability of brain 
volumes beyond their mean value. A conceptually and methodologically similar approach 
revealed genetic control of the variance in body height and body mass index 12. Adding to the 
notion that phenotypic spread in a population is related to genetic variability, the current results 
show that the population variance of cortical thickness and thalamus volume is partly under 
genetic control. Importantly, our findings on brain structure and the previous work on body mass 
index 12 provide converging evidence supporting the notion that common genetic variants 
affecting the mean and the variance of a trait need not be correlated and may influence 
phenotypes through complementary mechanisms.  
 Variants associated with volumetric dispersion were at loci that have previously been 
linked to neuropsychiatric traits. The significant variance locus for cortical thickness on 
chromosome 20 was located next to PAK7 - a gene conferring risk for psychosis and involved in 
oxytocin gene networks of the brain 20, 21 - and the synaptosome associated protein 25 gene 
(SNAP25) -which participates in synaptic function and increases susceptibility for severe 
psychiatric conditions 22, 23. Moreover, the 13q22 locus related to thalamus variance was near 
LINC00381, a non-protein coding RNA-gene that has recently been associated with hand 
preference in the UK Biobank 24.  
 Variance-controlling alleles can be interpreted as underlying distinct degrees of 
organismic robustness 1. Relevance to medical genetics also comes from the observation that 
several disease phenotypes emerge beyond a phenotypic threshold, which could be reached by 
the influence of high variability phenotypes 25. It is thus important to understand how the 
identified markers relate to brain variability under changing environments (robustness), how they 
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interact with other genetic loci (epistasis) and how they relate to the clinical manifestation of 
disease. Similarly, variance-controlling loci can underlie variability from other genetic factors, 
potentially affecting evolutionary dynamics 4. Identifying the mechanisms by which variance-
controlling genotypes influence gene expression variance in relevant brain structures may 
provide a proof of principle for the functional relevance of the identified genotypes. This type of 
effect on expression has been shown in model organisms 26, and the genomic loci identified here 
represent suitable candidates for targeted gene expression analysis in the human brain. The 
identification of specific genes involved in neural evolution and mental disorders suggests that 
brain variability in human populations is mediated by genetic factors. In so doing it also 
underscores the validity of gene-gene and gene-environment interactions in explaining 
heritability of complex human traits.  
While the present analysis does not follow an additive coding of alleles and thus may not 
be directly studied in relation to other GWAS datasets (e.g., through LD score regression), 
further research may elicit links between the variance-controlling genotypes and both mean and 
variance of other phenotypes. It is also important acknowledging that, even though the 
conventional mean-GWAS identified several hits (70 loci, as mentioned on Results), the 
variance-GWAS did not detect as many associations (2 loci). This is ostensibly due to statistical 
power constrains of variance tests such as Levene’s and GAMLSS, and it may also be related to 
the adopted conservative strategies including inverse-normal transformation and removal of low-
genotype count markers. Those steps, implemented to remove false positives, are probably 
overly conservative under some conditions; larger sample sizes may also aid the discovery of 
new loci.  
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 In summary, the results indicate that beyond associations with mean trait values, 
genotypic architecture modulates the variance of subcortical and intracranial dimensions across 
individuals. The lack of overlap between genetic associations detected by the standard additive 
genetic model and variance-controlling loci indicate independent mechanisms. These findings 
contribute to establish the genetic basis of phenotypic variance (i.e., heritability), allow 
identifying different degrees of brain robustness across individuals, and open new research 
avenues in the search for mechanisms controlling brain and mental health.   
 19
Supplementary information  
Supplementary information can be found with this article online.  
 
Author contributions  
Conceptualization, ACP and LTW; Methodology, ACP and LTW; Investigation, ACP, vdM, TK; 
Writing – Original Draft, ACP and LTW; Writing – Review & Editing, all co-authors.  
 
Declaration of interest  
The authors declare no competing interests.  
 
Data and code availability  
All scripts are available upon reasonable request to the corresponding authors. Data availability 
notes for each cohort can be found on Supplementary Table S1.  
 
Acknowledgements  
This work was funded by the South-Eastern Norway Regional Health Authority (2014097, 
2015073, 2016083, 2019101), the Research Council of Norway (204966, 249795, 223273), 
Stiftelsen Kristian Gerhard Jebsen, and the European Research Council under the European 
Union's Horizon 2020 research and Innovation program (ERC StG, Grant 802998). Research 




1. Félix MA, Barkoulas M. Pervasive robustness in biological systems. Nat Rev Genet 
2015; 16(8): 483-496. 
 
2. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N et al. 
Common genetic variants influence human subcortical brain structures. Nature 2015; 
520(7546): 224-229. 
 
3. Smeland OB, Wang Y, Frei O, Li W, Hibar DP, Franke B et al. Genetic Overlap Between 
Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume 
Indicates Shared Molecular Genetic Mechanisms. Schizophr Bull 2018; 44(4): 854-864. 
 
4. Wagner A. Robustness and evolvability in living systems. Princeton University Press: 
Princeton, N.J. ; Woodstock, 2005. 
 
5. Masel J, Trotter MV. Robustness and evolvability. Trends Genet 2010; 26(9): 406-414. 
 
6. Starrfelt J, Kokko H. Bet-hedging--a triple trade-off between means, variances and 
correlations. Biol Rev Camb Philos Soc 2012; 87(3): 742-755. 
 
7. Shen X, Pettersson M, Rönnegård L, Carlborg Ö. Inheritance beyond plain heritability: 
variance-controlling genes in Arabidopsis thaliana. PLoS Genet 2012; 8(8): e1002839. 
 
8. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation 
PLINK: rising to the challenge of larger and richer datasets. Gigascience 2015; 4: 7. 
 
9. R Core Team. R: A language and environment for statistical computing. R Foundation 
for Statistical Computing: Vienna, Austria, 2015. 
 
10. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic 
resonance images. Proceedings of the National Academy of Sciences of the United States 
of America 2000; 97(20): 11050-11055. 
 
11. Auer PL, Reiner AP, Leal SM. The effect of phenotypic outliers and non-normality on 
rare-variant association testing. Eur J Hum Genet 2016; 24(8): 1188-1194. 
 
12. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI et al. FTO 
genotype is associated with phenotypic variability of body mass index. Nature 2012; 
490(7419): 267-272. 
 
13. Shen X, Carlborg O. Beware of risk for increased false positive rates in genome-wide 
association studies for phenotypic variability. Front Genet 2013; 4: 93. 
 
 21
14. Ritchie SJ, Cox SR, Shen X, Lombardo MV, Reus LM, Alloza C et al. Sex Differences in 
the Adult Human Brain: Evidence from 5216 UK Biobank Participants. Cereb Cortex 
2018; 28(8): 2959-2975. 
 
15. Wierenga LM, Sexton JA, Laake P, Giedd JN, Tamnes CK, Pediatric Imaging Nu, and 
Genetics Study. A Key Characteristic of Sex Differences in the Developing Brain: 
Greater Variability in Brain Structure of Boys than Girls. Cereb Cortex 2018; 28(8): 
2741-2751. 
 
16. Stasinopoulos DM, Rigby RA. Generalized additive models for location scale and shape 
(GAMLSS) in R. Journal of Statistical Software 2007; 23(7): 1-46. 
 
17. Hastie T, Tibshirani R. Varyingcoefficient models. Journal of the Royal Statistical 
Society: Series B (Methodological) 1993; 55(4): 757-779. 
 
18. Franke B, Stein JL, Ripke S, Anttila V, Hibar DP, van Hulzen KJ et al. Genetic 
influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. 
Nat Neurosci 2016; 19(3): 420-431. 
 
19. Rousselet GA, Pernet CR, Wilcox RR. Beyond differences in means: robust graphical 
methods to compare two groups in neuroscience. Eur J Neurosci 2017; 46(2): 1738-1748. 
 
20. Morris DW, Pearson RD, Cormican P, Kenny EM, O'Dushlaine CT, Perreault LP et al. 
An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk 
factor for psychosis. Hum Mol Genet 2014; 23(12): 3316-3326. 
 
21. Quintana DS, Rokicki J, van der Meer D, Alnæs D, Kaufmann T, Córdova-Palomera A et 
al. Oxytocin pathway gene networks in the human brain. Nat Commun 2019; 10(1): 668. 
 
22. Houenou J, Boisgontier J, Henrion A, d'Albis MA, Dumaine A, Linke J et al. A 
Multilevel Functional Study of a. J Neurosci 2017; 37(43): 10389-10397. 
 
23. Najera K, Fagan BM, Thompson PM. SNAP-25 in Major Psychiatric Disorders: A 
Review. Neuroscience 2019. 
 
24. de Kovel CGF, Francks C. The molecular genetics of hand preference revisited. Sci Rep 
2019; 9(1): 5986. 
 
25. Ayroles JF, Buchanan SM, O'Leary C, Skutt-Kakaria K, Grenier JK, Clark AG et al. 
Behavioral idiosyncrasy reveals genetic control of phenotypic variability. Proc Natl Acad 
Sci U S A 2015; 112(21): 6706-6711. 
 
26. Huang W, Carbone MA, Magwire MM, Peiffer JA, Lyman RF, Stone EA et al. Genetic 
basis of transcriptome diversity in Drosophila melanogaster. Proc Natl Acad Sci U S A 





Figure legends  
Figure 1. Common genetic variants regulate the distribution variance of human subcortical and 
intracranial volumes  
Locus-zoom plots show all markers on the loci (just filtered by MAF during initial QC). Related 
plots, after the additional filter for minor (non-zero) genotype count are included as 
Supplementary Figure S4.  
 
Figure 2. Shift function plots for the top genome-wide significant associations in mean and 
variance model GWAS results  
The results corresponding to the top four mean models’ associations (conventional GWAS) are 
shown on the top rows (“A”, “B”), those corresponding to the top four variance model 
associations are displayed on the lower sections (“C”, “D”). A: Jittered marginal distribution 
scatterplots for the top two mean model associations, with overlaid shift function plots using 
deciles. Genotypes with the minor (effect) allele are shown as a single group. 95% confidence 
intervals were computed using a percentile bootstrap estimation of the standard error of the 
difference between quantiles on 1000 bootstrap samples. B: Linked deciles from shift functions 
on row “A”. C: Jittered marginal distribution scatterplots for the top two variance model 
associations, grouped by reference allele(s) versus effect allele(s) carriers. 95% confidence 
intervals were computed as in “A”. D: Linked deciles from shift functions on row “C”. For the 
mean model associations (“A” and “B”), variances explained by mean and variance parts of the 
model were 0.522% and 0.0004% (hippocampus, rs77956314), and 0.437% and 0.0015% 
(putamen, rs715732).  


